Abzena

Abzena is the leading end-to-end CDMO + CRO for ADCs, AOCs, RDCs & complex biologics. From discovery through commercial, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor our strategy to each project, Abzena develops and implements innovative solutions that enable biopharma companies to realize the full potential of their molecule and move medicines forward faster.